Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sulci Advisors is a strategic advisory firm specializing in the life sciences and biotechnology sectors. Founded by Dr. Michael Ehlers, a prominent neuroscientist and veteran biopharmaceutical executive, the firm provides expert guidance on R&D strategy, scientific innovation, and portfolio management. Sulci Advisors works with a range of clients, including venture capital firms, emerging biotech startups, and established pharmaceutical companies, to advance novel therapeutic programs. The firm's expertise is particularly deep in neuroscience and the translation of complex biological insights into clinical development plans. By bridging the gap between academic research and commercial drug development, Sulci Advisors plays a key role in shaping the trajectory of innovative healthcare companies. The firm is frequently engaged for its deep technical knowledge and strategic oversight in the creation of new biotech ventures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sulci Advisors.